This study emphasizes that it would be important to investigate PD-1 and PD-L1/PD-L2 expression in plaques from PAD patients as well, to assess whether the local tissue expression of these immune checkpoints differ from our findings in blood. The gene discussed is CD274; the disease is peripheral arterial disease.